Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' MELTZER HY' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 252 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Basile, VS; Ozdemir, V; Masellis, M; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, FM; Petronis, A; Kennedy, JL
      Lack of association between serotonin-2A receptor gene (HTR2A) polymorphisms and tardive dyskinesia in schizophrenia

      MOLECULAR PSYCHIATRY
    2. Meltzer, HY
      Perospirone - A viewpoint

      CNS DRUGS
    3. Masellis, M; Basile, VS; Meltzer, HY; Lieberman, JA; Sevy, S; Goldman, DA; Hamblin, MW; Macciardi, FM; Kennedy, JL
      Lack of association between the T -> C 267 serotonin 5-MT6 receptor gene (HTR6) polymorphism and prediction of response to clozapine in schizophrenia

      SCHIZOPHRENIA RESEARCH
    4. Niswender, CM; Herrick-Davis, K; Dilley, GE; Meltzer, HY; Overholser, JC; Stockmeier, CA; Emeson, RB; Sanders-Bush, E
      RNA editing of the human serotonin 5-MT2C receptor: Alterations in suicideand implications for serotonergic pharmacotherapy

      NEUROPSYCHOPHARMACOLOGY
    5. Lee, JH; Woo, JI; Meltzer, HY
      Effects of clozapine on sleep measures and sleep-associated changes in growth hormone and cortisol in patients with schizophrenia

      PSYCHIATRY RESEARCH
    6. Meltzer, HY; Fleischhacker, WW
      Weight gain: A growing problem in schizophrenia management

      JOURNAL OF CLINICAL PSYCHIATRY
    7. Basile, VS; Masellis, M; McIntyre, RS; Meltzer, HY; Lieberman, JA; Kennedy, JL
      Genetic dissection of atypical antipsychotic-induced weight gain: Novel preliminary data on the pharmacogenetic puzzle

      JOURNAL OF CLINICAL PSYCHIATRY
    8. Rauser, L; Savage, JE; Meltzer, HY; Roth, BL
      Inverse agonist actions of typical and atypical antipsychotic drugs at thehuman 5-hydroxytryptamine(2C) receptor

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    9. Ichikawa, J; Ishii, H; Bonaccorso, S; Fowler, WL; O'Laughlin, IA; Meltzer, HY
      5-HT2A and D-2 receptor blockade increases cortical DA release via 5-HT1A receptor activation: a possible mechanism of atypical antipsychotic-inducedcortical dopamine release

      JOURNAL OF NEUROCHEMISTRY
    10. Ichikawa, J; Dai, J; Meltzer, HY
      DOI, a 5-HT2A/2C receptor agonist, attenuates clozapine-induced cortical dopamine release

      BRAIN RESEARCH
    11. Lee, MA; Meltzer, HY
      5-HT1A receptor dysfunction in female patients with schizophrenia

      BIOLOGICAL PSYCHIATRY
    12. Sumiyoshi, T; Matsui, M; Yamashita, I; Nohara, S; Kurachi, M; Uehara, T; Sumiyoshi, S; Sumiyoshi, C; Meltzer, HY
      The effect of tandospirone, a serotonin(1A) agonist, on memory function inschizophrenia

      BIOLOGICAL PSYCHIATRY
    13. Klimek, V; Zhu, MY; Dilley, G; Konick, L; Overholser, JC; Meltzer, HY; May, WL; Stockmeier, CA; Ordway, GA
      Effects of long-term cigarette smoking on the human locus coeruleus

      ARCHIVES OF GENERAL PSYCHIATRY
    14. Sumiyoshi, T; Matsui, M; Nohara, S; Yamashita, I; Kurachi, M; Sumiyoshi, C; Jayathilake, K; Meltzer, HY
      Enhancement of cognitive performance in schizophrenia by addition of tandospirone to neuroleptic treatment

      AMERICAN JOURNAL OF PSYCHIATRY
    15. Shelton, RC; Tollefson, GD; Tohen, M; Stahl, S; Gannon, KS; Jacobs, TG; Buras, WR; Bymaster, FP; Zhang, W; Spencer, KA; Feldman, PD; Meltzer, HY
      A novel augmentation strategy for treating resistant major depression

      AMERICAN JOURNAL OF PSYCHIATRY
    16. Lee, MA; Meltzer, HY
      Substance abuse in schizophrenia - Biological factors mediating comorbidity and the potential role of atypical antipsychotic drugs

      SUBSTANCE ABUSE IN THE MENTALLY AND PHYSICALLY DISABLED
    17. Meltzer, HY; Anand, R; Alphs, L
      Reducing suicide risk in schizophrenia - Focus on the role of clozapine

      CNS DRUGS
    18. McGurk, SR; Meltzer, HY
      The role of cognition in vocational functioning in schizophrenia

      SCHIZOPHRENIA RESEARCH
    19. Park, S; Knopick, C; McGurk, S; Meltzer, HY
      Nicotine impairs spatial working memory while leaving spatial attention intact

      NEUROPSYCHOPHARMACOLOGY
    20. Sumiyoshi, T; Matsui, M; Yamashita, I; Nohara, S; Uehara, T; Kurachi, M; Meltzer, HY
      Effect of adjunctive treatment with serotonin-1A agonist tandospirone on memory functions in schizophrenia

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    21. Meltzer, HY
      Schizophrenia in a molecular age: Review of psychiatry, vol 18

      JOURNAL OF CLINICAL PSYCHIATRY
    22. Meltzer, HY
      The rise of psychopharmacology and the story of CINP

      JOURNAL OF CLINICAL PSYCHIATRY
    23. Meltzer, HY
      Introduction: Side effects of antipsychotic medications: Physician's choice of medication and patient compliance

      JOURNAL OF CLINICAL PSYCHIATRY
    24. Conley, RR; Meltzer, HY
      Adverse events related to olanzapine

      JOURNAL OF CLINICAL PSYCHIATRY
    25. Kuroki, T; Dai, J; Meltzer, HY; Ichikawa, J
      R(+)-8-OH-DPAT, a selective 5-HT1A receptor agonist, attenuated amphetamine-induced dopamine synthesis in rat striatum, but not nucleus accumbens or medial prefrontal cortex

      BRAIN RESEARCH
    26. Ichikawa, J; Meltzer, HY
      The effect of serotonin(1A) receptor agonism on antipsychotic drug-induceddopamine release in rat striatum and nucleus accumbens

      BRAIN RESEARCH
    27. Miguel-Hidalgo, JJ; Baucom, C; Dilley, G; Overholser, JC; Meltzer, HY; Stockmeier, CA; Rajkowska, G
      Glial fibrillary acidic protein immunoreactivity in the prefrontal cortex distinguishes younger from older adults in major depressive disorder

      BIOLOGICAL PSYCHIATRY
    28. Meltzer, HY
      Genetics and etiology of schizophrenia and bipolar disorder

      BIOLOGICAL PSYCHIATRY
    29. Masellis, M; Basile, VS; Ozdemir, V; Meltzer, HY; Macciardi, FM; Kennedy, JL
      Pharmacogenetics of antipsychotic treatment: Lessons learned from clozapine

      BIOLOGICAL PSYCHIATRY
    30. Vincent, JB; Neves-Pereira, ML; Paterson, AD; Yamamoto, E; Parikh, SV; Macciardi, F; Gurling, HMD; Potkin, SG; Pato, CN; Macedo, A; Kovacs, M; Davies, M; Lieberman, JA; Meltzer, HY; Petronis, A; Kennedy, JL
      An unstable trinucleotide-repeat region on chromosome 13 implicated in spinocerebellar ataxia: A common expansion lotus

      AMERICAN JOURNAL OF HUMAN GENETICS
    31. Meltzer, HY
      Massive serum creatine kinase increases with atypical antipsychotic drugs:what is the mechanism and the message?

      PSYCHOPHARMACOLOGY
    32. Meltzer, HY
      An atypical compound by any other name is still a ....

      PSYCHOPHARMACOLOGY
    33. Vincent, JB; Petronis, A; Strong, E; Parikh, SV; Meltzer, HY; Lieberman, J; Kennedy, JL
      Analysis of genome-wide CAG CTG repeats, and at SEF2-1B and ERDA1 in schizophrenia and bipolar affective disorder

      MOLECULAR PSYCHIATRY
    34. Ichikawa, J; Meltzer, HY
      Relationship between dopaminergic and serotonergic neuronal activity in the frontal cortex and the action of typical and atypical antipsychotic drugs

      EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE
    35. Lee, MA; Jayathilake, K; Meltzer, HY
      A comparison of the effect of clozapine with typical neuroleptics on cognitive function in neuroleptic-responsive schizophrenia

      SCHIZOPHRENIA RESEARCH
    36. Meltzer, HY
      The role of serotonin in antipsychotic drug action

      NEUROPSYCHOPHARMACOLOGY
    37. Basile, VS; Masellis, M; Badri, F; Paterson, AD; Meltzer, HY; Lieberman, JA; Potkin, SG; Macciardi, F; Kennedy, JL
      Association of the MscI polymorphism of the dopamine D3 receptor gene withtardive dyskinesia in schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    38. Klimek, V; Rajkowska, G; Luker, SN; Dilley, G; Meltzer, HY; Overholser, JC; Stockmeier, CA; Ordway, GA
      Brain noradrenergic receptors in major depression and schizophrenia

      NEUROPSYCHOPHARMACOLOGY
    39. Meltzer, HY; McGurk, SR
      The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

      SCHIZOPHRENIA BULLETIN
    40. Maes, M; Libbrecht, I; van Hunsel, F; Campens, D; Meltzer, HY
      Pindolol and mianserin augment the antidepressant activity of fluoxetine in hospitalized major depressed patients, including those with treatment resistance

      JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
    41. Maes, M; Christophe, A; Delanghe, J; Altamura, C; Neels, H; Meltzer, HY
      Lowered omega 3 polyunsaturated fatty acids in serum phospholipids and cholesteryl esters of depressed patients

      PSYCHIATRY RESEARCH
    42. Meltzer, HY
      A beautiful mind: A biography of John Forbes Nash, Jr.

      JOURNAL OF CLINICAL PSYCHIATRY
    43. Meltzer, HY
      Outcome in schizophrenia: Beyond symptom reduction

      JOURNAL OF CLINICAL PSYCHIATRY
    44. Meltzer, HY
      Suicide and schizophrenia: Clozapine and the InterSePT study

      JOURNAL OF CLINICAL PSYCHIATRY
    45. Meltzer, HY; Jayathilake, K
      Low-dose loxapine in the treatment of schizophrenia: Is it more effective and more "atypical" than standard-dose loxapine?

      JOURNAL OF CLINICAL PSYCHIATRY
    46. Meltzer, HY; Park, S; Kessler, R
      Cognition, schizophrenia, and the atypical antipsychotic drugs

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    47. Ichikawa, J; Meltzer, HY
      R(+)-8-OH-DPAT, a serotonin(1A) receptor agonist, potentiated S(2)-sulpiride-induced dopamine release in rat medial prefrontal cortex and nucleus accumbens but not striatum

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    48. Kuroki, T; Meltzer, HY; Ichikawa, J
      Effects of antipsychotic drugs on extracellular dopamine levels in rat medial prefrontal cortex and nucleus accumbens

      JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
    49. Ichikawa, J; Meltzer, HY
      Valproate and carbamazepine increase prefrontal dopamine release by 5-HT1Areceptor activation

      EUROPEAN JOURNAL OF PHARMACOLOGY
    50. Ordway, GA; Farley, JT; Dilley, GE; Overholser, JC; Meltzer, HY; Balraj, EK; Stockmeier, CA; Klimek, V
      Quantitative distribution of monoamine oxidase A in brainstem monoamine nuclei is normal in major depression

      BRAIN RESEARCH
    51. Ichikawa, J; Meltzer, HY
      The effect of ipsapirone and S(-)-pindolol on dopamine release in rat striatum and nucleus accumbens

      BRAIN RESEARCH
    52. Zhu, MY; Klimek, V; Dilley, GE; Haycock, JW; Stockmeier, C; Overholser, JC; Meltzer, HY; Ordway, GA
      Elevated levels of tyrosine hydroxylase in the locus coeruleus in major depression

      BIOLOGICAL PSYCHIATRY
    53. Meltzer, HY
      Treatment of schizophrenia and spectrum disorders: Pharmacotherapy, psychosocial treatments, and neurotransmitter interactions

      BIOLOGICAL PSYCHIATRY
    54. Meltzer, HY
      Dopamine, receptor occupancy and the action of clozapine: Does it make a difference to add a neuroleptic?

      BIOLOGICAL PSYCHIATRY
    55. Rajkowska, G; Miguel-Hidalgo, JJ; Wei, JR; Dilley, G; Pittman, SD; Meltzer, HY; Overholser, JC; Roth, BL; Stockmeier, CA
      Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression

      BIOLOGICAL PSYCHIATRY
    56. Meyers, BS; Alexopoulos, GS; Kakuma, T; Tirumalasetti, F; Gabriele, M; Alpert, S; Bowden, C; Meltzer, HY
      Decreased dopamine beta-hydroxylase activity in unipolar geriatric delusional depression

      BIOLOGICAL PSYCHIATRY
    57. Maes, M; Van Gastel, A; Delmeire, L; Meltzer, HY
      Decreased platelet alpha-2 adrenoceptor density in major depression: Effects of tricyclic antidepressants and fluoxetine

      BIOLOGICAL PSYCHIATRY
    58. Meltzer, HY
      Risperidone and clozapine for treatment-resistant schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    59. Truffinet, P; Tamminga, CA; Fabre, LF; Meltzer, HY; Riviere, ME; Papillon-Downey, C
      Placebo-controlled study of the D-4/5-HT2A antagonist fananserin in the treatment of schizophrenia

      AMERICAN JOURNAL OF PSYCHIATRY
    60. Young, CD; Bubser, M; Meltzer, HY; Deutch, AY
      Clozapine pretreatment modifies haloperidol-elicited forebrain Fos induction: a regionally-specific double dissociation

      PSYCHOPHARMACOLOGY
    61. SUMMERFELT WT; MELTZER HY
      EFFICACY VS. EFFECTIVENESS IN PSYCHIATRIC RESEARCH

      Psychiatric services
    62. HONG WW; RAK IW; CIURYLA VT; WILSON AM; KYLSTRA JW; MELTZER HY; CARPENTER WT; LEHMAN A; ARVANITIS LA
      MEDICAL-CLAIMS DATABASES IN THE DESIGN OF A HEALTH-OUTCOMES COMPARISON OF QUETIAPINE (SEROQUEL) AND USUAL-CARE ANTIPSYCHOTIC MEDICATION

      Schizophrenia research
    63. PETRONIS A; VINCENT JB; PATERSON AD; BASSETT AS; HONER WG; GOTTESMAN II; TORREY EF; MELTZER HY; LIEBERMAN J; KENNEDY JL
      SEARCH FOR UNSTABLE DNA IN SCHIZOPHRENIA

      Schizophrenia research
    64. MCGURK SR; MELTZER HY
      THE EFFECTS OF ATYPICAL ANTIPSYCHOTIC-DRUGS ON COGNITIVE-FUNCTIONING IN SCHIZOPHRENIA

      Schizophrenia research
    65. MASELLIS M; BASILE V; MELTZER HY; LIEBERMAN JA; SEVY S; MACCIARDI FM; COLA P; HOWARD A; BADRI F; NOTHEN MM; KALOW W; KENNEDY JL
      SEROTONIN SUBTYPE-2 RECEPTOR GENES AND CLINICAL-RESPONSE TO CLOZAPINEIN SCHIZOPHRENIA-PATIENTS

      Neuropsychopharmacology
    66. YOUNG CD; MELTZER HY; DEUTCH AY
      EFFECTS OF DESMETHYLCLOZAPINE ON FOS PROTEIN EXPRESSION IN THE FOREBRAIN - IN-VIVO BIOLOGICAL-ACTIVITY OF THE CLOZAPINE METABOLITE

      Neuropsychopharmacology
    67. MELTZER HY; PRINGUEY D
      TREATMENT-RESISTANT SCHIZOPHRENIA - THE IMPORTANCE OF EARLY DETECTIONAND TREATMENT - PROCEEDINGS OF A SYMPOSIUM HELD AT THE 6TH WORLD CONGRESS OF BIOLOGICAL PSYCHIATRY, NICE, FRANCE, JUNE 22, 1997 - INTRODUCTION

      Journal of clinical psychopharmacology
    68. MELTZER HY; LEE M; COLA P
      THE EVOLUTION OF TREATMENT RESISTANCE - BIOLOGIC IMPLICATIONS

      Journal of clinical psychopharmacology
    69. MELTZER HY
      SUICIDE IN SCHIZOPHRENIA - RISK-FACTORS AND CLOZAPINE TREATMENT

      The Journal of clinical psychiatry
    70. MELTZER HY; CASEY DE; GARVER DL; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      MEASURING OUTCOME IN SCHIZOPHRENIA - DIFFERENCES AMONG THE ATYPICAL ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    71. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      CLINICAL DEVELOPMENT OF ATYPICAL ANTIPSYCHOTICS - RESEARCH DESIGN ANDEVALUATION

      The Journal of clinical psychiatry
    72. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      ADVERSE-EFFECTS OF THE ATYPICAL ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    73. MELTZER HY; CASEY DE; GARVER DL; LASAGNA S; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      ASSESSMENT OF EPS AND TARDIVE-DYSKINESIA IN CLINICAL-TRIALS

      The Journal of clinical psychiatry
    74. MELTZER HY; CASEY DE; GARVER DL; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      ASSESSING THE EFFECTS OF ATYPICAL ANTIPSYCHOTICS ON NEGATIVE SYMPTOMS

      The Journal of clinical psychiatry
    75. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      EVALUATING THE EFFECTS OF ANTIPSYCHOTICS ON COGNITION IN SCHIZOPHRENIA

      The Journal of clinical psychiatry
    76. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      ATYPICAL ANTIPSYCHOTICS FOR TREATMENT OF DEPRESSION IN SCHIZOPHRENIA AND AFFECTIVE-DISORDERS

      The Journal of clinical psychiatry
    77. MELTZER HY; CASEY DE; GARVER DL; LASAGNA L; MARDER SR; MASAND PS; MILLER D; PICKAR D; TANDON R
      TREATMENT OF SPECIAL POPULATIONS WITH THE ATYPICAL ANTIPSYCHOTICS

      The Journal of clinical psychiatry
    78. JOPE RS; SONG L; GRIMES CA; PACHECO MA; DILLEY GE; LI XH; MELTZER HY; OVERHOLSER JC; STOCKMEIER CA
      SELECTIVE INCREASES IN PHOSPHOINOSITIDE SIGNALING ACTIVITY AND G-PROTEIN LEVELS IN POSTMORTEM BRAIN FROM SUBJECTS WITH SCHIZOPHRENIA OR ALCOHOL DEPENDENCE

      Journal of neurochemistry
    79. ICHIKAWA J; KUROKI T; DAI J; MELTZER HY
      EFFECT OF ANTIPSYCHOTIC-DRUGS ON EXTRACELLULAR SEROTONIN LEVELS IN RAT MEDIAL PREFRONTAL CORTEX AND NUCLEUS-ACCUMBENS

      European journal of pharmacology
    80. ICHIKAWA J; KUROKI T; MELTZER HY
      DIFFERENTIAL-EFFECTS OF CHRONIC IMIPRAMINE AND FLUOXETINE ON BASAL AND AMPHETAMINE-INDUCED EXTRACELLULAR DOPAMINE LEVELS IN RAT NUCLEUS-ACCUMBENS

      European journal of pharmacology
    81. FATEMI SH; SIDWELL R; KIST D; AKHTER P; MELTZER HY; BAILEY K; THURAS P; SEDGWICK J
      DIFFERENTIAL EXPRESSION OF SYNAPTOSOME-ASSOCIATED PROTEIN-25 KDA [SNAP-25] IN HIPPOCAMPI OF NEONATAL MICE FOLLOWING EXPOSURE TO HUMAN INFLUENZA-VIRUS IN-UTERO

      Brain research
    82. WILLINS DL; MELTZER HY
      SEROTONIN 5-HT2C AGONISTS SELECTIVELY INHIBIT MORPHINE-INDUCED DOPAMINE EFFLUX IN THE NUCLEUS-ACCUMBENS

      Brain research
    83. RAJKOWSKA G; WEI J; PITTMAN SD; PAGE W; RICHMOND M; DILLEY G; MELTZER HY; OVERHOLSER JC; STOCKMEIER CA
      HISTOPATHOLOGY OF THE ORBITOFRONTAL CORTEX IN MAJOR DEPRESSION

      Biological psychiatry
    84. LEE M; MELTZER HY
      EFFECT OF APOMORPHINE ON PLASMA-CORTISOL IN SCHIZOPHRENIA

      Biological psychiatry
    85. MELTZER HY
      ZIPRASIDONE - VIEWPOINT

      CNS DRUGS
    86. BUCKLEY PF; FRIEDMAN L; WU D; LAI S; MELTZER HY; HAACKE EM; MILLER D; LEWIN JS
      FUNCTIONAL MAGNETIC-RESONANCE-IMAGING IN SCHIZOPHRENIA - INITIAL METHODOLOGY AND EVALUATION OF THE MOTOR CORTEX

      PSYCHIATRY RESEARCH-NEUROIMAGING
    87. MAES M; BOSMANS E; KENIS G; DEJONG R; SMITH RS; MELTZER HY
      IN-VIVO IMMUNOMODULATORY EFFECTS OF CLOZAPINE IN SCHIZOPHRENIA

      Schizophrenia research
    88. STOCKMEIER CA; SONG L; DILLEY GE; MELTZER HY; OVERHOLSER JC; JOPE RS
      PHOSPHOINOSITIDE SIGNALING ACTIVITY IN POSTMORTEM BRAIN FROM SUBJECTSWITH SCHIZOPHRENIA OR ALCOHOL DEPENDENCE

      Schizophrenia research
    89. VINCENT JB; MELTZER HY; LIEBERMAN JA; BRESCHEL T; MCGINNIS M; MACEDO A; AZEVEDO MH; PATO CN; TORREY EF; GOTTESMAN II; PETRONIS A; KENNEDY JL
      LARGE OR EXPANDED CAG CTG TRINUCLEOTIDE REPEATS AS AN ETIOLOGIC FACTOR IN SCHIZOPHRENIA/

      Schizophrenia research
    90. MCGURK SR; LEE M; MELTZER HY
      RELATIONSHIP BETWEEN PLASMA-CORTISOL AND COGNITIVE FUNCTION IN SCHIZOPHRENIA

      Schizophrenia research
    91. SUMIYOSHI T; ICHIKAWA J; MELTZER HY
      THE EFFECT OF STREPTOZOTOCIN-INDUCED DIABETES ON DOPAMINE(2), SEROTONIN(1A) AND SEROTONIN(2A) RECEPTORS IN THE RAT-BRAIN

      Neuropsychopharmacology
    92. STOCKMEIER CA; DILLEY GE; SHAPIRO LA; OVERHOLSER JC; THOMPSON PA; MELTZER HY
      SEROTONIN RECEPTORS IN SUICIDE VICTIMS WITH MAJOR DEPRESSION

      Neuropsychopharmacology
    93. MELTZER HY
      TREATMENT-RESISTANT SCHIZOPHRENIA - THE ROLE OF CLOZAPINE

      Current medical research and opinion
    94. MAES M; WESTENBERG H; VANDOOLAEGHE E; DEMEDTS P; WAUTERS A; NEELS H; MELTZER HY
      EFFECTS OF TRAZODONE AND FLUOXETINE IN THE TREATMENT OF MAJOR DEPRESSION - THERAPEUTIC PHARMACOKINETIC AND PHARMACODYNAMIC INTERACTIONS THROUGH FORMATION OF META-CHLOROPHENYLPIPERAZINE

      Journal of clinical psychopharmacology
    95. ALSEMAAN YM; CLAY HA; MELTZER HY
      CLOZAPINE IN TREATMENT OF BROMOCRIPTINE-INDUCED PSYCHOSIS

      Journal of clinical psychopharmacology
    96. PARSA MA; SZIGETHY E; VOCI JM; MELTZER HY
      RISPERIDONE IN TREATMENT OF CHOREOATHETOSIS OF HUNTINGTONS-DISEASE

      Journal of clinical psychopharmacology
    97. KLIMEK V; STOCKMEIER C; OVERHOLSER J; MELTZER HY; KALKA S; DILLEY G; ORDWAY GA
      REDUCED LEVELS OF NOREPINEPHRINE TRANSPORTERS IN THE LOCUS-COERULEUS IN MAJOR DEPRESSION

      The Journal of neuroscience
    98. MAES M; CALABRESE J; JAYATHILAKE K; MELTZER HY
      EFFECTS OF SUBCHRONIC TREATMENT WITH VALPROATE ON L-5-HTP-INDUCED CORTISOL RESPONSES IN MANIA - EVIDENCE FOR INCREASED CENTRAL SEROTONERGICNEUROTRANSMISSION

      Psychiatry research
    99. SUMIYOSHI T; HASEGAWA M; JAYATHILAKE K; MELTZER HY
      PREDICTION OF SHORT-TERM CHANGES IN SYMPTOM SEVERITY BY BASE-LINE PLASMA HOMOVANILLIC-ACID LEVELS IN SCHIZOPHRENIC-PATIENTS RECEIVING CLOZAPINE

      Psychiatry research
    100. MAES M; DELANGE J; RANJAN R; MELTZER HY; DESNYDER R; COOREMANS W; SCHARPE S
      ACUTE-PHASE PROTEINS IN SCHIZOPHRENIA, MANIA AND MAJOR DEPRESSION - MODULATION BY PSYCHOTROPIC-DRUGS

      Psychiatry research


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 04/06/20 alle ore 07:47:39